Trial intelligence / Profile preview

Topical Morphine for Analgesia in Pediatric Procedures

NCT02300194Phase 4Withdrawn

Sponsor
Hospital General de Niños Pedro de Elizalde
Start
Dec 2014
Primary completion
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in pain comparing Topic Morphine with Placebo (2 arms). Primary endpoint: Pain Reduction (FLACC scale) at 4 hours. Planned start Dec 2014; status: withdrawn.

02

Drugs

morphine hydrochloride
03

Conditions

pain

Beyond the preview

Go deeper on NCT02300194.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02300194.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call